News
-
-
-
PRESS RELEASE
A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
Japan approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as Prescription Drug for Vulnerable Infants, supported by clinical evidence and regulatory milestones